Home
Analyst Insights
Company News
Markets
Top Picks

Adaptimmune Therapeutics Plc ADR

Adaptimmune Therapeutics Plc ADR (ADAP) with a beta value of 2.37 appears to be a promising investment opportunity.

September 29, 2025

Sana Meer

On Friday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) opened higher 15.75% from the last session, before settling in for the ...

Most recent

Top Picks

No matter how cynical the overall market is Agios Pharmaceuticals Inc (AGIO) performance over the last week is recorded 3.26%

Markets

$1.15M in average volume shows that RH (RH) is heading in the right direction

Company News

Recent developments with Oklo Inc (OKLO) have led to the company’s beta value being reach 0.67 cents.

Analyst Insights

Indaptus Therapeutics Inc (INDP) posted a 25.54% change over the last five days signaling a new trend

Top Picks

Aclaris Therapeutics Inc (ACRS) is destined for greater heights as its last quarter sales were 1,780 K

Markets

A major move is in the offing as Hims & Hers Health Inc (HIMS) market cap hits 13.20 billion

Newsdaemon.com is a business and stock news platform offering in-depth market coverage, aiming to expand readers’ understanding of public and private capital sharing through updates and detailed analysis.

Quick Links

About Us
Contact Us
Disclaimer
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled